In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies to produce Victoza, also known as liraglutide, following a proposal by ...
The drug is known generically as liraglutide, which the FDA says has been in short supply “with certain other GLP-1 medications.” This references the consistent shortages for drugs like semaglutides, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback